(Q30368552)

21 June 2017

1 reference

title

Influenza-associated bacterial pneumonia; managing and controlling infection on two fronts. (English)

1 reference

21 June 2017

1 reference

2

Samira Mubareka

1 reference

21 June 2017

Aaron Campigotto

1

1 reference

21 June 2017

publication date

11 November 2014

1 reference

Expert Review of Anti-infective Therapy

21 June 2017

published in

1 reference

21 June 2017

volume

13

1 reference

21 June 2017

issue

1

1 reference

21 June 2017

page(s)

55-68

1 reference

The annual impact of seasonal influenza in the US: Measuring disease burden and costs

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Comparison of shedding characteristics of seasonal influenza virus (sub)types and influenza A(H1N1)pdm09; Germany, 2007-2011

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Influenza A and B virus infections in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Clinical review: primary influenza viral pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Disease severity in patients with simultaneous influenza and bacterial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Postinfluenza bacterial pneumonia: host defenses gone awry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Identifying the interaction between influenza and pneumococcal pneumonia using incidence data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Viral-bacterial interactions-therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

1918 Influenza: the mother of all pandemics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Autopsy series of 68 cases dying before and during the 1918 influenza pandemic peak

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Pathogenic responses among young adults during the 1918 influenza pandemic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Critically ill patients with 2009 influenza A(H1N1) infection in Canada.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

The impact of bacterial and viral co-infection in severe influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

The occurrence and impact of bacterial organisms complicating critical care illness associated with 2009 influenza A(H1N1) infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Pneumococcal disease seasonality: incidence, severity and the role of influenza activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Serotype-specific effect of influenza on adult invasive pneumococcal pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Effect of the 2009 influenza A(H1N1) pandemic on invasive pneumococcal pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Impact of the 2009 influenza A H1N1 pandemic on invasive pneumococcal disease in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Critically ill children during the 2009-2010 influenza pandemic in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Pneumonia caused by methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Community-acquired pneumonia due to pandemic A(H1N1)2009 influenzavirus and methicillin resistant Staphylococcus aureus co-infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Myocardial injury and bacterial pneumonia contribute to the pathogenesis of fatal influenza B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Otolaryngological complications in patients infected with the influenza A (H1N1) virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Meningococcal disease and influenza-like syndrome: a new approach to an old question.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

A 20-year ecological study of the temporal association between influenza and meningococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Influenza A and meningococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

The co-pathogenesis of influenza viruses with bacteria in the lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Adherence of type I Streptococcus pneumoniae to tracheal epithelium of mice infected with influenza A/PR8 virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Insights into the interaction between influenza virus and pneumococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Influenza promotes pneumococcal growth during coinfection by providing host sialylated substrates as a nutrient source.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Influenza virus infection decreases tracheal mucociliary velocity and clearance of Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Potential role for alternatively activated macrophages in the secondary bacterial infection during recovery from influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Kinetics of coinfection with influenza A virus and Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Type I interferon induction during influenza virus infection increases susceptibility to secondary Streptococcus pneumoniae infection by negative regulation of γδ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Dysregulated macrophage-inflammatory protein-2 expression drives illness in bacterial superinfection of influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Microbiota regulates immune defense against respiratory tract influenza A virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Commensal bacteria calibrate the activation threshold of innate antiviral immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Influenza virus aerosols in human exhaled breath: particle size, culturability, and effect of surgical masks

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Exposure to influenza virus aerosols during routine patient care

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Aerosol transmission is an important mode of influenza A virus spread

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Transocular entry of seasonal influenza-attenuated virus aerosols and the efficacy of n95 respirators, surgical masks, and eye protection in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Whole-genome sequencing shows that patient-to-patient transmission rarely accounts for acquisition of Staphylococcus aureus in an intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Whole-genome sequencing for analysis of an outbreak of meticillin-resistant Staphylococcus aureus: a descriptive study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Effect of influenza A virus infection on nasopharyngeal colonization and otitis media induced by transparent or opaque phenotype variants of Streptococcus pneumoniae in the chinchilla model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Associations between pathogens in the upper respiratory tract of young children: interplay between viruses and bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Influenza A virus facilitates Streptococcus pneumoniae transmission and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Synergistic role of staphylococcal proteases in the induction of influenza virus pathogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Role of the microbiology laboratory in the diagnosis of lower respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Bacterial infection in exacerbated COPD with changes in sputum characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Nucleic Acid Amplification Tests for the Diagnosis of Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Biological markers to determine eligibility in trials for community-acquired pneumonia: a focus on procalcitonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Role of procalcitonin and C-reactive protein in differentiation of mixed bacterial infection from 2009 H1N1 viral pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Can procalcitonin tests aid in identifying bacterial infections associated with influenza pneumonia? A systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Imaging of pulmonary viral pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

CT of viral lower respiratory tract infections in adults: comparison among viral organisms and between viral and bacterial infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Outcomes of adults hospitalised with severe influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Influenza virus neuraminidase contributes to secondary bacterial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Oseltamivir and risk of lower respiratory tract complications in patients with flu symptoms: a meta-analysis of eleven randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Why don't we have all the evidence on oseltamivir?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Ensuring safe and effective drugs: who can do what it takes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Neuraminidase inhibitors for treatment and prophylaxis of influenza in children: systematic review and meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Coeliac disease and risk of tuberculosis: A population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Doxycycline treatment attenuates acute lung injury in mice infected with virulent influenza H3N2 virus: involvement of matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Leucomycin A3, a 16-membered macrolide antibiotic, inhibits influenza A virus infection and disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Macrolide-based regimens in absence of bacterial co-infection in critically ill H1N1 patients with primary viral pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Linezolid decreases susceptibility to secondary bacterial pneumonia postinfluenza infection in mice through its effects on IFN-γ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Treatment with protein synthesis inhibitors improves outcomes of secondary bacterial pneumonia after influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Effect of linezolid on clinical severity and pulmonary cytokines in a murine model of influenza A and Staphylococcus aureus coinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Therapeutic effect of erythromycin on influenza virus-induced lung injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Adjunctive corticosteroid therapy improves lung immunopathology and survival during severe secondary pneumococcal pneumonia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Marked improvement of severe lung immunopathology by influenza-associated pneumococcal superinfection requires the control of both bacterial replication and host immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

H1N1 influenza A virus-associated acute lung injury: response to combination oseltamivir and prolonged corticosteroid treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Association between use of statins and mortality among patients hospitalized with laboratory-confirmed influenza virus infections: a multistate study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Live attenuated influenza vaccine, but not pneumococcal conjugate vaccine, protects against increased density and duration of pneumococcal carriage after influenza infection in pneumococcal colonized mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Inactivated and live, attenuated influenza vaccines protect mice against influenza: Streptococcus pyogenes super-infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Impact of 13-valent pneumococcal conjugate vaccine (PCV13) in a pandemic similar to the 2009 H1N1 in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Effectiveness of vaccination with 23-valent pneumococcal polysaccharide vaccine in preventing hospitalization with laboratory confirmed influenza during the 2009-2010 and 2010-2011 seasons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Benefit of conjugate pneumococcal vaccination in preventing influenza hospitalization in children: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Efficacy of face masks and respirators in preventing upper respiratory tract bacterial colonization and co-infection in hospital healthcare workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Bacterial pneumonia and pandemic influenza planning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

High nasopharyngeal pneumococcal density, increased by viral coinfection, is associated with invasive pneumococcal pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

HIV and influenza virus infections are associated with increased blood pneumococcal load: a prospective, hospital-based observational study in South Africa, 2009-2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Swine flu and antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Intervention strategies for an influenza pandemic taking into account secondary bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

The guinea pig as a transmission model for human influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Pneumolysin expression by streptococcus pneumoniae protects colonized mice from influenza virus-induced disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Early Corticosteroids in Severe Influenza A/H1N1 Pneumonia and Acute Respiratory Distress Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

Role of Staphylococcus protease in the development of influenza pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.2015.981156

10.1586/14787210.2015.981156

21 January 2018

Identifiers

DOI

1 reference

21 June 2017

1 reference